PCN61 US BUDGET IMPACT ANALYSIS OF BENDAMUSTINE READY-TO-DILUTE PRODUCTS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA

Value in Health ◽

10.1016/j.jval.2020.04.1564 ◽

2020 ◽

Vol 23 ◽

pp. S34

Author(s):

E. James ◽

H. Trautman ◽

E. Szabo ◽

R. Ribalov

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Hodgkin Lymphoma ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Lymphocytic Leukemia ◽

Non Hodgkin Lymphoma

Download Full-text

Budget Impact Analysis of the Incorporation of Ibrutinib for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in the Brazilian Private Health Care System

Value in Health ◽

10.1016/j.jval.2016.03.1551 ◽

2016 ◽

Vol 19 (3) ◽

pp. A143

Author(s):

H Paiva ◽

E Asano

Keyword(s):

Health Care ◽

Chronic Lymphocytic Leukemia ◽

Health Care System ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Lymphocytic Leukemia ◽

Private Health Care ◽

Download Full-text

PCN106 Cost-Minimization and Budget Impact Analysis of Venetoclax plus Obinutuzumab Versus Ibrutinib in Patients with Untreated Chronic Lymphocytic Leukemia in the Brazilian Private Healthcare System

Value in Health ◽

10.1016/j.jval.2021.04.198 ◽

2021 ◽

Vol 24 ◽

pp. S39

Author(s):

F.M. Vieira ◽

G.N. Ribeiro ◽

Filho C Brito ◽

A. Travassos

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Cost Minimization ◽

Budget Impact Analysis ◽

Lymphocytic Leukemia ◽

Private Healthcare

Download Full-text

PBI9 BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENTS

Value in Health ◽

10.1016/j.jval.2020.04.078 ◽

2020 ◽

Vol 23 ◽

pp. S15

Author(s):

T. Abbott ◽

C. Balmaceda ◽

M.A. Espinoza

Keyword(s):

Hodgkin Lymphoma ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Public System ◽

Rituximab Maintenance ◽

Non Hodgkin Lymphoma

Download Full-text

BUDGET IMPACT ANALYSIS FOR THE FIRST-LINE AND SECOND-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Value in Health ◽

10.1016/j.jval.2016.03.1045 ◽

2016 ◽

Vol 19 (3) ◽

pp. A244-A245

Author(s):

J. Lachaine ◽

C.T. Kouroukis

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Lymphocytic Leukemia ◽

Line Treatment ◽

Second Line ◽

Download Full-text

Budget Impact Analysis of Obinutuzumab And Ibrutinib In Patients With Chronic Lymphocytic Leukemia In Russia

Value in Health ◽

10.1016/j.jval.2016.09.1356 ◽

2016 ◽

Vol 19 (7) ◽

pp. A582

Author(s):

EV Derkach ◽

OY Rebrova ◽

VK Fedyaeva

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Lymphocytic Leukemia

Download Full-text

To Evaluate the Safety and Tolerability, Find an Appropriate Dose to Optimize Safety and Efficacy, and Evaluate Clinical Activity of PBCAR20A in Subjects With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) or r/r Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Case Medical Research ◽

10.31525/ct1-nct04030195 ◽

2019 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

Clinical Activity ◽

Small Lymphocytic Lymphoma ◽

Safety And Efficacy ◽

Non Hodgkin Lymphoma

Download Full-text

Faculty Opinions recommendation of Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1072097.525084 ◽

2007 ◽

Author(s):

Emili Montserrat

Keyword(s):

Chronic Lymphocytic Leukemia ◽

B Cell ◽

Hodgkin Lymphoma ◽

Light Chain ◽

Free Light Chain ◽

Lymphocytic Leukemia ◽

Serum Free Light Chain ◽

Non Hodgkin Lymphoma

Download Full-text

Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients

Leukemia & Lymphoma ◽

10.3109/10428194.2010.505675 ◽

2010 ◽

Vol 51 (11) ◽

pp. 2120-2125 ◽

Author(s):

Pimjai Niparuck ◽

Wasana Kanoksil ◽

Suporn Chuncharunee ◽

Paisarn Boonsakan ◽

Artit Ungkanont ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Chronic Lymphocytic Leukemia ◽

Myelodysplastic Syndrome ◽

Hodgkin Lymphoma ◽

Myeloid Leukemia ◽

Lymphocytic Leukemia ◽

Non Hodgkin Lymphoma ◽

Download Full-text

Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia

Future Oncology ◽

10.2217/fon-2017-0574 ◽

2018 ◽

Vol 14 (17) ◽

pp. 1691-1699 ◽

Author(s):

Samuel Luke Hill ◽

Andrew Davies

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Hodgkin Lymphoma ◽

Lymphocytic Leukemia ◽

Non Hodgkin Lymphoma ◽

Recombinant Human Hyaluronidase

Download Full-text

Phase II Study of Interleukin-4 in Indolent B-cell Non-Hodgkin Lymphoma and B-cell Chronic Lymphocytic Leukemia: A Study of the Eastern Cooperative Oncology Group (E5Y92)

Journal of Immunotherapy ◽

10.1097/cji.0b013e3181f5dfc5 ◽

2010 ◽

Vol 33 (9) ◽

pp. 1006-1009 ◽

Author(s):

Peter H. Wiernik ◽

Janice P. Dutcher ◽

Xiapan Yao ◽

Usha Venkatraj ◽

Carla I. Falkson ◽

...

Keyword(s):

Chronic Lymphocytic Leukemia ◽

B Cell ◽

Hodgkin Lymphoma ◽

Phase Ii Study ◽

Eastern Cooperative Oncology Group ◽

Lymphocytic Leukemia ◽

Interleukin 4 ◽

Oncology Group ◽

Non Hodgkin Lymphoma ◽

Cell Chronic Lymphocytic Leukemia

Download Full-text